{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T06:23:03Z","timestamp":1791181383846,"version":"4.1.0"},"reference-count":96,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["biologicalpsychiatryjournal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biological Psychiatry"],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1016\/j.biopsych.2010.06.016","type":"journal-article","created":{"date-parts":[[2010,8,22]],"date-time":"2010-08-22T04:28:51Z","timestamp":1282451331000},"page":"785-794","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":414,"title":["Magnetic Resonance Spectroscopy Studies of Glutamate-Related Abnormalities in Mood Disorders"],"prefix":"10.1016","volume":"68","author":[{"given":"Cagri","family":"Y\u00fcksel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dost","family":"\u00d6ng\u00fcr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopsych.2010.06.016_bib1","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1001\/archpsyc.62.6.593","article-title":"Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the national comorbidity survey replication","volume":"62","author":"Kessler","year":"2005","journal-title":"Arch Gen Psychiatry"},{"issue":"suppl 8","key":"10.1016\/j.biopsych.2010.06.016_bib2","first-page":"4","article-title":"The burden of depression and anxiety in general medicine","volume":"62","author":"Lecrubier","year":"2001","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.biopsych.2010.06.016_bib3","year":"2002"},{"key":"10.1016\/j.biopsych.2010.06.016_bib4","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1001\/archpsyc.59.6.530","article-title":"The long-term natural history of the weekly symptomatic status of bipolar I disorder","volume":"59","author":"Judd","year":"2002","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.biopsych.2010.06.016_bib5","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1176\/ajp.2006.163.11.1905","article-title":"Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: A STAR*D report","volume":"163","author":"Rush","year":"2006","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.biopsych.2010.06.016_bib6","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jad.2008.10.014","article-title":"What happens to patients with treatment-resistant depression","volume":"116","author":"Fekadu","year":"2009","journal-title":"J. J Affect Disord"},{"key":"10.1016\/j.biopsych.2010.06.016_bib7","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1017\/S1092852900010403","article-title":"Beyond monoamines: Glutamatergic function in mood disorders","volume":"10","author":"Kugaya","year":"2005","journal-title":"CNS Spectr"},{"key":"10.1016\/j.biopsych.2010.06.016_bib8","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.tips.2009.09.002","article-title":"Glutamate-based antidepressants: 20 Years on","volume":"30","author":"Skolnick","year":"2009","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.biopsych.2010.06.016_bib9","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/nrd2462","article-title":"Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders","volume":"7","author":"Sanacora","year":"2008","journal-title":"Nat Rev Drug Discov"},{"issue":"suppl 1","key":"10.1016\/j.biopsych.2010.06.016_bib10","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1038\/sj.mp.4001021","article-title":"Glutamate and GABA systems as targets for novel antidepressant and mood-stabilizing treatments","volume":"7","author":"Krystal","year":"2002","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.biopsych.2010.06.016_bib11","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0301-0082(90)90013-7","article-title":"Metabolism and role of glutamate in mammalian brain","volume":"35","author":"Erecinska","year":"1990","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.biopsych.2010.06.016_bib12","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1111\/j.1471-4159.2006.03913.x","article-title":"The glutamate\/GABA-glutamine cycle: Aspects of transport, neurotransmitter homeostasis and ammonia transfer","volume":"98","author":"Bak","year":"2006","journal-title":"J Neurochem"},{"key":"10.1016\/j.biopsych.2010.06.016_bib13","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1023\/A:1022397704922","article-title":"Role of astrocytes in the maintenance and modulation of glutamatergic and GABAergic neurotransmission","volume":"28","author":"Schousboe","year":"2003","journal-title":"Neurochem Res"},{"key":"10.1016\/j.biopsych.2010.06.016_bib14","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.neuint.2005.04.012","article-title":"Role of glutamine and neuronal glutamate uptake in glutamate homeostasis and synthesis during vesicular release in cultured glutamatergic neurons","volume":"47","author":"Waagepetersen","year":"2005","journal-title":"Neurochem Int"},{"key":"10.1016\/j.biopsych.2010.06.016_bib15","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.tins.2004.10.008","article-title":"Astrocytic control of glutamatergic activity: Astrocytes as stars of the show","volume":"27","author":"Hertz","year":"2004","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.biopsych.2010.06.016_bib16","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1111\/j.1471-4159.1984.tb05406.x","article-title":"Alteration of striatal glutamate release after glutamine synthetase inhibition","volume":"43","author":"Rothstein","year":"1984","journal-title":"J Neurochem"},{"key":"10.1016\/j.biopsych.2010.06.016_bib17","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1111\/j.1471-4159.1989.tb07263.x","article-title":"Role of glial cells for the basal and Ca2+-dependent K+-evoked release of transmitter amino acids investigated by microdialysis","volume":"52","author":"Paulsen","year":"1989","journal-title":"J Neurochem"},{"key":"10.1016\/j.biopsych.2010.06.016_bib18","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1001\/archgenpsychiatry.2009.86","article-title":"Altered prefrontal glutamate-glutamine-gamma-aminobutyric acid levels and relation to low cognitive performance and depressive symptoms in type 1 diabetes mellitus","volume":"66","author":"Lyoo","year":"2009","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.biopsych.2010.06.016_bib19","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.bcp.2009.04.008","article-title":"Targeting glial physiology and glutamate cycling in the treatment of depression","volume":"78","author":"Valentine","year":"2009","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.biopsych.2010.06.016_bib20","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1176\/ajp.115.11.1025","article-title":"Cyloserine as an antidepressant agent","volume":"115","author":"Crane","year":"1959","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.biopsych.2010.06.016_bib21","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0006-3223(99)00230-9","article-title":"Antidepressant effects of ketamine in depressed patients","volume":"47","author":"Berman","year":"2000","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2010.06.016_bib22","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1001\/archpsyc.63.8.856","article-title":"A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression","volume":"63","author":"Zarate","year":"2006","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.biopsych.2010.06.016_bib23","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1517\/14656566.6.8.1401","article-title":"Lamotrigine in the treatment of bipolar disorder","volume":"6","author":"Bhagwagar","year":"2005","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.biopsych.2010.06.016_bib24","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1017\/S1092852900010324","article-title":"Lamotrigine augmentation strategy for patients with treatment-resistant depression","volume":"10","author":"Gutierrez","year":"2005","journal-title":"CNS Spectr"},{"key":"10.1016\/j.biopsych.2010.06.016_bib25","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1176\/appi.ajp.163.2.210","article-title":"Treatment-resistant bipolar depression: A STEP-BD equipoise randomized effectiveness trial of antidepressant augmentation with lamotrigine, inositol, or risperidone","volume":"163","author":"Nierenberg","year":"2006","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.biopsych.2010.06.016_bib26","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1176\/appi.ajp.161.11.2132","article-title":"Riluzole augmentation for treatment-resistant depression","volume":"161","author":"Sanacora","year":"2004","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.biopsych.2010.06.016_bib27","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.biopsych.2006.08.037","article-title":"Preliminary evidence of riluzole efficacy in antidepressant-treated patients with residual depressive symptoms","volume":"61","author":"Sanacora","year":"2007","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2010.06.016_bib28","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1176\/appi.ajp.161.1.171","article-title":"An open-label trial of riluzole in patients with treatment-resistant major depression","volume":"161","author":"Zarate","year":"2004","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.biopsych.2010.06.016_bib29","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.biopsych.2004.11.023","article-title":"An open-label trial of the glutamate-modulating agent riluzole in combination with lithium for the treatment of bipolar depression","volume":"57","author":"Zarate","year":"2005","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2010.06.016_bib30","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/npp.2009.191","article-title":"Rapid enhancement of glutamatergic neurotransmission in bipolar depression following treatment with riluzole","volume":"35","author":"Brennan","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopsych.2010.06.016_bib31","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/BF02761776","article-title":"Chronic administration of imipramine and citalopram alters the expression of NMDA receptor subunit mRNAs in mouse brain","volume":"10","author":"Boyer","year":"1998","journal-title":"J Mol Neurosci"},{"key":"10.1016\/j.biopsych.2010.06.016_bib32","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1055\/s-2007-979537","article-title":"Adaptation of N-methyl-D-aspartate (NMDA) receptors following antidepressant treatment: implications for the pharmacotherapy of depression","volume":"29","author":"Skolnick","year":"1996","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.biopsych.2010.06.016_bib33","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.biopsych.2005.10.018","article-title":"Regulation of editing and expression of glutamate alpha-amino-propionic-acid (AMPA)\/ kainate receptors by antidepressant drugs","volume":"59","author":"Barbon","year":"2006","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2010.06.016_bib34","doi-asserted-by":"crossref","first-page":"117","DOI":"10.2174\/187152707780363258","article-title":"AMPA receptors in the therapeutic management of depression","volume":"6","author":"Bleakman","year":"2007","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"10.1016\/j.biopsych.2010.06.016_bib35","doi-asserted-by":"crossref","first-page":"3270","DOI":"10.1523\/JNEUROSCI.5033-04.2005","article-title":"Chronic antidepressants reduce depolarization-evoked glutamate release and protein interactions favoring formation of SNARE complex in hippocampus","volume":"25","author":"Bonanno","year":"2005","journal-title":"J Neurosci"},{"key":"10.1016\/j.biopsych.2010.06.016_bib36","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S0306-4522(00)00390-0","article-title":"Imipramine and phenelzine decrease glutamate overflow in the prefrontal cortex\u2014a possible mechanism of neuroprotection in major depression?","volume":"100","author":"Michael-Titus","year":"2000","journal-title":"Neuroscience"},{"key":"10.1016\/j.biopsych.2010.06.016_bib37","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1176\/ajp.150.11.1731","article-title":"Plasma and platelet excitatory amino acids in psychiatric disorders","volume":"150","author":"Altamura","year":"1993","journal-title":"Am J Psychiatry"},{"issue":"suppl","key":"10.1016\/j.biopsych.2010.06.016_bib38","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0924-977X(95)00033-L","article-title":"Plasma concentrations of excitatory amino acids, serine, glycine, taurine and histidine in major depression","volume":"5","author":"Altamura","year":"1995","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.biopsych.2010.06.016_bib39","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/BF00345492","article-title":"Increased serum glutamate in depressed patients","volume":"232","author":"Kim","year":"1982","journal-title":"Arch Psychiatr Nervenkr"},{"key":"10.1016\/j.biopsych.2010.06.016_bib40","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1159\/000026491","article-title":"Plasma and platelet amino acid concentrations in patients affected by major depression and under fluvoxamine treatment","volume":"37","author":"Mauri","year":"1998","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.biopsych.2010.06.016_bib41","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/j.1600-0447.1998.tb10004.x","article-title":"Serum levels of excitatory amino acids, serine, glycine, histidine, threonine, taurine, alanine and arginine in treatment-resistant depression: Modulation by treatment with antidepressants and prediction of clinical responsivity","volume":"97","author":"Maes","year":"1998","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.biopsych.2010.06.016_bib42","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/S0006-3223(99)00284-X","article-title":"Increased cerebrospinal fluid glutamine levels in depressed patients","volume":"47","author":"Levine","year":"2000","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2010.06.016_bib43","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1192\/bjp.160.5.638","article-title":"Effect of psychotropic drugs on excitatory amino acids in patients undergoing psychosurgery for depression","volume":"160","author":"Pangalos","year":"1992","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.biopsych.2010.06.016_bib44","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.biopsych.2006.01.024","article-title":"Low cerebrospinal fluid glutamate and glycine in refractory affective disorder","volume":"61","author":"Frye","year":"2007","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2010.06.016_bib45","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/0006-8993(89)90600-8","article-title":"Brain amino acid concentrations and Ca2+-dependent release in intractable depression assessed antemortem","volume":"494","author":"Francis","year":"1989","journal-title":"Brain Res"},{"key":"10.1016\/j.biopsych.2010.06.016_bib46","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/j.biopsych.2007.03.017","article-title":"Increased levels of glutamate in brains from patients with mood disorders","volume":"62","author":"Hashimoto","year":"2007","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2010.06.016_bib47","doi-asserted-by":"crossref","first-page":"13290","DOI":"10.1073\/pnas.95.22.13290","article-title":"Glial reduction in the subgenual prefrontal cortex in mood disorders","volume":"95","author":"Ongur","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biopsych.2010.06.016_bib48","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/S0006-3223(99)00041-4","article-title":"Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression","volume":"45","author":"Rajkowska","year":"1999","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2010.06.016_bib49","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/S0361-9230(01)00527-5","article-title":"Glial cell abnormalities in major psychiatric disorders: The evidence and implications","volume":"55","author":"Cotter","year":"2001","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.biopsych.2010.06.016_bib50","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S0006-3223(01)01080-0","article-title":"Reductions in neuronal and glial density characterize the dorsolateral prefrontal cortex in bipolar disorder","volume":"49","author":"Rajkowska","year":"2001","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2010.06.016_bib51","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/S0006-3223(02)01404-X","article-title":"Low glial numbers in the amygdala in major depressive disorder","volume":"52","author":"Bowley","year":"2002","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2010.06.016_bib52","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.biopsych.2003.11.006","article-title":"Glial reduction in amygdala in major depressive disorder is due to oligodendrocytes","volume":"55","author":"Hamidi","year":"2004","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2010.06.016_bib53","doi-asserted-by":"crossref","first-page":"15653","DOI":"10.1073\/pnas.0507901102","article-title":"Altered cortical glutamatergic and GABAergic signal transmission with glial involvement in depression","volume":"102","author":"Choudary","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biopsych.2010.06.016_bib54","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1038\/sj.npp.1301604","article-title":"Lamina-specific abnormalities of NMDA receptor-associated postsynaptic protein transcripts in the prefrontal cortex in schizophrenia and bipolar disorder","volume":"33","author":"Beneyto","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopsych.2010.06.016_bib55","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.1097\/00001756-200109170-00043","article-title":"Asymmetrical reductions of hippocampal NMDAR1 glutamate receptor mRNA in the psychoses","volume":"12","author":"Law","year":"2001","journal-title":"Neuroreport"},{"key":"10.1016\/j.biopsych.2010.06.016_bib56","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.brainres.2006.09.011","article-title":"Decreased NR1, NR2A, and SAP102 transcript expression in the hippocampus in bipolar disorder","volume":"1127","author":"McCullumsmith","year":"2007","journal-title":"Brain Res"},{"key":"10.1016\/j.biopsych.2010.06.016_bib57","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1038\/sj.npp.1300781","article-title":"Elevated levels of the NR2C subunit of the NMDA receptor in the locus coeruleus in depression","volume":"30","author":"Karolewicz","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopsych.2010.06.016_bib58","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S0361-9230(01)00523-8","article-title":"Striatal ionotropic glutamate receptor expression in schizophrenia, bipolar disorder, and major depressive disorder","volume":"55","author":"Meador-Woodruff","year":"2001","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.biopsych.2010.06.016_bib59","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1002\/syn.20329","article-title":"Lamina-specific abnormalities of AMPA receptor trafficking and signaling molecule transcripts in the prefrontal cortex in schizophrenia","volume":"60","author":"Beneyto","year":"2006","journal-title":"Synapse"},{"key":"10.1016\/j.biopsych.2010.06.016_bib60","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0006-3223(99)00159-6","article-title":"Reduced glutamate in the anterior cingulate cortex in depression: An in vivo proton magnetic resonance spectroscopy study","volume":"47","author":"Auer","year":"2000","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2010.06.016_bib61","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1001\/archgenpsychiatry.2009.39","article-title":"The relationship between aberrant neuronal activation in the pregenual anterior cingulate, altered glutamatergic metabolism, and anhedonia in major depression","volume":"66","author":"Walter","year":"2009","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.biopsych.2010.06.016_bib62","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1002\/jmri.20214","article-title":"Neurochemistry of late-life major depression: A pilot two-dimensional MR spectroscopic study","volume":"20","author":"Binesh","year":"2004","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.biopsych.2010.06.016_bib63","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1001\/archpsyc.61.7.705","article-title":"Subtype-specific alterations of gamma-aminobutyric acid and glutamate in patients with major depression","volume":"61","author":"Sanacora","year":"2004","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.biopsych.2010.06.016_bib64","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0925-4927(03)00003-9","article-title":"Effective electroconvulsive therapy reverses glutamate\/glutamine deficit in the left anterior cingulum of unipolar depressed patients","volume":"122","author":"Pfleiderer","year":"2003","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.biopsych.2010.06.016_bib65","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1017\/S0033291703007931","article-title":"Metabolic changes within the left dorsolateral prefrontal cortex occurring with electroconvulsive therapy in patients with treatment resistant unipolar depression","volume":"33","author":"Michael","year":"2003","journal-title":"Psychol Med"},{"key":"10.1016\/j.biopsych.2010.06.016_bib66","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1001\/archpsyc.64.2.193","article-title":"Reduced prefrontal glutamate\/glutamine and gamma-aminobutyric acid levels in major depression determined using proton magnetic resonance spectroscopy","volume":"64","author":"Hasler","year":"2007","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.biopsych.2010.06.016_bib67","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1038\/sj.npp.1300085","article-title":"Neurotrophic effects of electroconvulsive therapy: A proton magnetic resonance study of the left amygdalar region in patients with treatment-resistant depression","volume":"28","author":"Michael","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopsych.2010.06.016_bib68","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1017\/S1461145708009516","article-title":"Proton MR spectroscopy of the hippocampus at 3 T in patients with unipolar major depressive disorder: Correlates and predictors of treatment response","volume":"12","author":"Block","year":"2008","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.biopsych.2010.06.016_bib69","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.neuroimage.2009.03.031","article-title":"Hippocampal metabolic abnormalities at first onset and with recurrent episodes of a major depressive disorder: A proton magnetic resonance spectroscopy study","volume":"47","author":"Milne","year":"2009","journal-title":"Neuroimage"},{"key":"10.1016\/j.biopsych.2010.06.016_bib70","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.biopsych.2008.10.025","article-title":"Amino acid neurotransmitters assessed by proton magnetic resonance spectroscopy: Relationship to treatment resistance in major depressive disorder","volume":"65","author":"Price","year":"2008","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2010.06.016_bib71","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.biopsych.2005.05.017","article-title":"Normal prefrontal gamma-aminobutyric acid levels in remitted depressed subjects determined by proton magnetic resonance spectroscopy","volume":"58","author":"Hasler","year":"2005","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2010.06.016_bib72","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.biopsych.2006.08.048","article-title":"Reduction in occipital cortex gamma-aminobutyric acid concentrations in medication-free recovered unipolar depressed and bipolar subjects","volume":"61","author":"Bhagwagar","year":"2007","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2010.06.016_bib73","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.biopsych.2008.05.014","article-title":"Abnormal glutamatergic neurotransmission and neuronal-glial interactions in acute mania","volume":"64","author":"Ongur","year":"2008","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2010.06.016_bib74","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1038\/mp.2008.26","article-title":"Glutamate as a spectroscopic marker of hippocampal structural plasticity is elevated in long-term euthymic bipolar patients on chronic lithium therapy and correlates inversely with diurnal cortisol","volume":"14","author":"Colla","year":"2008","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.biopsych.2010.06.016_bib75","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1001\/archpsyc.61.5.450","article-title":"Brain metabolic alterations in medication-free patients with bipolar disorder","volume":"61","author":"Dager","year":"2004","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.biopsych.2010.06.016_bib76","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1038\/sj.npp.1301387","article-title":"Increased anterior cingulate\/medial prefrontal cortical glutamate and creatine in bipolar depression","volume":"32","author":"Frye","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopsych.2010.06.016_bib77","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/sj.mp.4002130","article-title":"Metabonomic analysis identifies molecular changes associated with the pathophysiology and drug treatment of bipolar disorder","volume":"14","author":"Lan","year":"2009","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.biopsych.2010.06.016_bib78","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1007\/s00213-003-1440-z","article-title":"Acute mania is accompanied by elevated glutamate\/glutamine levels within the left dorsolateral prefrontal cortex","volume":"168","author":"Michael","year":"2003","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.biopsych.2010.06.016_bib79","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.pscychresns.2008.07.007","article-title":"Increased choline-containing compounds in the orbitofrontal cortex and hippocampus in euthymic patients with bipolar disorder: A proton magnetic resonance spectroscopy study","volume":"172","author":"Senaratne","year":"2009","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.biopsych.2010.06.016_bib80","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.pscychresns.2009.01.002","article-title":"Elevated metabolites within dorsolateral prefrontal cortex in rapid cycling bipolar disorder","volume":"172","author":"Michael","year":"2009","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.biopsych.2010.06.016_bib81","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.pscychresns.2007.08.004","article-title":"Metabolic alterations in medication-free patients with bipolar disorder: A 3T CSF-corrected magnetic resonance spectroscopic imaging study","volume":"162","author":"Port","year":"2008","journal-title":"Psychiatry Res"},{"issue":"suppl 1","key":"10.1016\/j.biopsych.2010.06.016_bib82","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1399-5618.2007.00454.x","article-title":"Abnormal cellular energy and phospholipid metabolism in the left dorsolateral prefrontal cortex of medication-free individuals with bipolar disorder: An in vivo 1H MRS study","volume":"9","author":"Frey","year":"2007","journal-title":"Bipolar Disord"},{"key":"10.1016\/j.biopsych.2010.06.016_bib83","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1146\/annurev.physiol.65.092101.142131","article-title":"In vivo NMR studies of the glutamate neurotransmitter flux and neuroenergetics: Implications for brain function","volume":"65","author":"Rothman","year":"2003","journal-title":"Annu Rev Physiol"},{"key":"10.1016\/j.biopsych.2010.06.016_bib84","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/(SICI)1097-4547(19990815)57:4<417::AID-JNR1>3.0.CO;2-N","article-title":"Astrocytes: Glutamate producers for neurons","volume":"57","author":"Hertz","year":"1999","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.biopsych.2010.06.016_bib85","first-page":"976","article-title":"Magnetic resonance spectroscopy in psychiatry: Potential, pitfalls, and promise","volume":"148","author":"Keshavan","year":"1991","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.biopsych.2010.06.016_bib86","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1046\/j.1440-1614.2002.00992.x","article-title":"Magnetic resonance spectroscopy and its applications in psychiatry","volume":"36","author":"Malhi","year":"2002","journal-title":"Aust N Z J Psychiatry"},{"key":"10.1016\/j.biopsych.2010.06.016_bib87","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1176\/appi.ajp.159.11.1944","article-title":"Glutamate and glutamine measured with 4.0 T proton MRS in never-treated patients with schizophrenia and healthy volunteers","volume":"159","author":"Theberge","year":"2002","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.biopsych.2010.06.016_bib88","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1002\/nbm.1385","article-title":"Neurochemical changes in the rat prefrontal cortex following acute phencyclidine treatment: An in vivo localized (one) H MRS study","volume":"22","author":"Iltis","year":"2009","journal-title":"NMR Biomed"},{"key":"10.1016\/j.biopsych.2010.06.016_bib89","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/S0006-8993(01)02579-3","article-title":"1H magnetic resonance spectroscopic imaging of permanent focal cerebral ischemia in rat: Longitudinal metabolic changes in ischemic core and rim","volume":"907","author":"Igarashi","year":"2001","journal-title":"Brain Res"},{"key":"10.1016\/j.biopsych.2010.06.016_bib90","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1046\/j.1471-4159.2002.01161.x","article-title":"Glial uptake of neurotransmitter glutamate from the extracellular fluid studied in vivo by microdialysis and (13) C NMR","volume":"83","author":"Kanamori","year":"2002","journal-title":"J Neurochem"},{"key":"10.1016\/j.biopsych.2010.06.016_bib91","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1046\/j.1471-4159.2001.00074.x","article-title":"In vivo (13)C NMR measurement of neurotransmitter glutamate cycling, anaplerosis and TCA cycle flux in rat brain during","volume":"76","author":"Sibson","year":"2001","journal-title":"J Neurochem"},{"key":"10.1016\/j.biopsych.2010.06.016_bib92","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.neuroimage.2005.06.016","article-title":"Metabolic alterations in focally activated primary somatosensory cortex of alpha-chloralose-anesthetized rats measured by 1H MRS at 11.7 T","volume":"28","author":"Xu","year":"2005","journal-title":"Neuroimage"},{"key":"10.1016\/j.biopsych.2010.06.016_bib93","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1002\/mrm.21447","article-title":"Quantitative proton spectroscopic imaging of the neurochemical profile in rat brain with microliter resolution at ultra-short echo times","volume":"59","author":"Mlynarik","year":"2008","journal-title":"Magn Reson Med"},{"key":"10.1016\/j.biopsych.2010.06.016_bib94","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1001\/archpsyc.1985.01790280019002","article-title":"Cerebral metabolic rates for glucose in mood disorders","volume":"42","author":"Baxter","year":"1985","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.biopsych.2010.06.016_bib95","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1001\/jama.1987.03400100102031","article-title":"The differential diagnosis of depression","volume":"258","author":"Schwartz","year":"1987","journal-title":"JAMA"},{"key":"10.1016\/j.biopsych.2010.06.016_bib96","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/npp.2009.104","article-title":"Neurocircuitry of mood disorders","volume":"35","author":"Price","year":"2010","journal-title":"Neuropsychopharmacology"}],"container-title":["Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006322310006050?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006322310006050?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T14:54:55Z","timestamp":1757775295000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006322310006050"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11]]},"references-count":96,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2010,11]]}},"alternative-id":["S0006322310006050"],"URL":"https:\/\/doi.org\/10.1016\/j.biopsych.2010.06.016","relation":{},"ISSN":["0006-3223"],"issn-type":[{"value":"0006-3223","type":"print"}],"subject":[],"published":{"date-parts":[[2010,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Magnetic Resonance Spectroscopy Studies of Glutamate-Related Abnormalities in Mood Disorders","name":"articletitle","label":"Article Title"},{"value":"Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopsych.2010.06.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Society of Biological Psychiatry. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}